311 related articles for article (PubMed ID: 22981547)
41. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect.
Václavík J; Táborský M; Richter D
Clin Exp Hypertens; 2013; 35(3):192-4. PubMed ID: 22891761
[TBL] [Abstract][Full Text] [Related]
42. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
[TBL] [Abstract][Full Text] [Related]
43. The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trial.
Vink EE; de Beus E; de Jager RL; Voskuil M; Spiering W; Vonken EJ; de Wit GA; Roes KC; Bots ML; Blankestijn PJ
Am Heart J; 2014 Mar; 167(3):308-314.e3. PubMed ID: 24576513
[TBL] [Abstract][Full Text] [Related]
44. Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension.
Damascelli B; Patelli G; Tichá V; Della Rocca F; Lattuada S; Sala C; Albertoni A; D'Alessio A; Funaro A; Scotti L
J Vasc Interv Radiol; 2013 May; 24(5):632-9. PubMed ID: 23622036
[TBL] [Abstract][Full Text] [Related]
45. Renal denervation--hypes and hopes.
Lewek J; Kaczmarek K; Pokushalov E; Romanov A; Cygankiewicz I; Ptaszynski P
Cardiovasc Ther; 2015 Jun; 33(3):141-4. PubMed ID: 25786785
[TBL] [Abstract][Full Text] [Related]
46. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.
Esler MD; Krum H; Schlaich M; Schmieder RE; Böhm M; Sobotka PA;
Circulation; 2012 Dec; 126(25):2976-82. PubMed ID: 23248063
[TBL] [Abstract][Full Text] [Related]
47. Comparing cost-effectiveness analyses of anti-hypertensive drug therapy for decision making: mission impossible?
Mullins CD; Blak BT; Akhras KS
Value Health; 2002; 5(4):359-71. PubMed ID: 12102698
[TBL] [Abstract][Full Text] [Related]
48. Does renal artery supply indicate treatment success of renal denervation?
Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326
[TBL] [Abstract][Full Text] [Related]
49. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
[TBL] [Abstract][Full Text] [Related]
50. Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence.
Sharp ASP; Cao KN; Esler MD; Kandzari DE; Lobo MD; Schmieder RE; Pietzsch JB
Eur Heart J Qual Care Clin Outcomes; 2024 Jan; ():. PubMed ID: 38196127
[TBL] [Abstract][Full Text] [Related]
51. Renal denervation as therapy for hypertension: potentials and unanswered questions.
Vink EE; Bots ML; Blankestijn PJ
Eur J Prev Cardiol; 2013 Dec; 20(6):980-91. PubMed ID: 23610453
[TBL] [Abstract][Full Text] [Related]
52. [The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension].
Wang L; Lu CZ; Zhang X; Luo D; Zhao B; Yu X; Xia DS; Chen X; Zhao XD
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jan; 41(1):3-7. PubMed ID: 23651959
[TBL] [Abstract][Full Text] [Related]
53. Effect of renal nerve denervation for resistant hypertension in Thai patients: a report of the first cases series in Thailand.
Wongpraparut N; Tresukosol D; Roubsantisuk W; Buranakitjaroen P; Chotivoraniyakul C; Pongakasira R
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S155-61. PubMed ID: 24772593
[TBL] [Abstract][Full Text] [Related]
54. Catheter-based renal denervation for treatment of resistant hypertension.
Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
[TBL] [Abstract][Full Text] [Related]
55. Recent developments in renal denervation.
Raphael CE; Davies JE
Minerva Cardioangiol; 2013 Jun; 61(3):271-80. PubMed ID: 23681130
[TBL] [Abstract][Full Text] [Related]
56. Renal Denervation in High-Risk Patients With Hypertension.
Mahfoud F; Mancia G; Schmieder R; Narkiewicz K; Ruilope L; Schlaich M; Whitbourn R; Zirlik A; Zeller T; Stawowy P; Cohen SA; Fahy M; Böhm M
J Am Coll Cardiol; 2020 Jun; 75(23):2879-2888. PubMed ID: 32527396
[TBL] [Abstract][Full Text] [Related]
57. [Economic efficiency of renal denervation in patients with resistant hypertension: results of Markov modeling].
Kontsevaia AV; Suvorova EI; Khudiakov MB
Kardiologiia; 2014; 54(1):41-7. PubMed ID: 24881310
[TBL] [Abstract][Full Text] [Related]
58. ESH position paper: renal denervation - an interventional therapy of resistant hypertension.
Schmieder RE; Redon J; Grassi G; Kjeldsen SE; Mancia G; Narkiewicz K; Parati G; Ruilope L; van de Borne P; Tsioufis C
J Hypertens; 2012 May; 30(5):837-41. PubMed ID: 22469838
[TBL] [Abstract][Full Text] [Related]
59. Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial.
Jin Y; Jacobs L; Baelen M; Thijs L; Renkin J; Hammer F; Kefer J; Petit T; Verhamme P; Janssens S; Sinnaeve P; Lengelé JP; Persu A; Staessen JA;
Blood Press; 2014 Jun; 23(3):138-46. PubMed ID: 24742341
[TBL] [Abstract][Full Text] [Related]
60. Potential health impact and cost-effectiveness of drug therapy for prehypertension.
Chen T; Yu D; Cornelius V; Qin R; Cai Y; Jiang Z; Zhao Z
Int J Cardiol; 2017 Aug; 240():403-408. PubMed ID: 28501349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
